Chronic glucose feeding accompanied by glucose injection (i.p.) causes sustained hyperglycaemia and hypertension in rats. The exact reason for the hypertension is not known. We explore some molecular pathways of the renal proximal tubule that might promote Na + retention. r What is the main finding and its importance?
Introduction
Dietary intervention is a common strategy to induce chronic hyperglycaemia in animals to emulate the diabetic complications observed in humans. Numerous studies show that dietary supply of excess nutrients such as fructose, sucrose, glucose or fat to animals or other subjects for a period of time can induce sustained hyperglycaemia, resulting in many diabetic complications, including hypertension, insulin resistance and nephropathy (Chen et al. 2010; Lozano et al. 2016; Fakhruddin et al. 2017b ). In our recent study (Fakhruddin et al. 2017b) , we observed that oral and I.P. glucose loading for a period of 2 weeks significantly elevated blood glucose concentrations concurrent with hyperinsulinaemia and hypertension. In line with this observation, some studies showed that feeding animals glucose-enriched diets for 2-7 weeks promoted an elevation in blood pressure (BP) without significant changes in plasma glucose concentrations (Kaufman et al. 1991; Reaven & Ho, 1991) . The elevated BP has been attributed to an increase in sympathetic nervous system stimulation and/or hyperinsulinaemia (Kaufman et al. 1991) .
Hyperglycaemia can induce an elevation in blood pressure via numerous pathways. One of the potential pathways involved in raising blood pressure is the renin-angiotensin-aldosterone system (RAAS), which is responsible for systemic and local production of angiotensin II (Ang II), a potent vasoconstrictor. Conventionally, the effects of the RAAS were considered to be mediated by its circulating components, such as renin, angiotensinogen, angiotensin-converting enzyme (ACE) and Ang II. However, physiological, biochemical and molecular studies have demonstrated convincing evidence that RAAS components can also be produced in local tissues, such as brain, heart, testes, kidney, β-cells and vasculature (Dostal & Baker, 1999; Graciano et al. 2004; Paul et al. 2006) . Although the systemic RAAS has an important role in elevating blood pressure, growing scientific evidence has shown that intrarenal upregulation of the RAAS can be involved in raising BP and renal injury in diabetic conditions (Mizuno et al. 2002; Kobori et al. 2007; Suzaki et al. 2007) .
Angiotensin II, a potent vasoconstrictor component of the RAAS, can be increased independently of the plasma concentrations in the interstitial fluid of the kidney cortex in response to different pathological conditions (Nishiyama et al. 2002; Nagai et al. 2005; Prathipati et al. 2015) . In addition to Ang II, other RAAS components, such as angiotensinogen, ACE, the angiotensin II type 1 receptor (AT 1 R) and renin can be overexpressed, especially in the proximal tubule (PT) of the renal cortex (Nagai et al. 2005; Luo et al. 2015) . The RAAS components overexpressed in the kidney cortex in a diabetic milieu cause dysregulation of fluid homeostasis through diverse signalling pathways, leading to increased Na + reabsorption followed by increased extracellular fluid volume. Several studies have shown that hyperglycaemia-induced upregulation of Ang II increases its interaction with the AT 1 R to elicit various pathological responses, including enhanced aldosterone secretion, increased fluid reabsorption through the proximal tubule, increased reactive oxygen species (ROS) and renovascular constriction Navar, 2004; Leehey et al. 2000) . Angiotensin II along with high glucose can significantly increase the generation of ROS through activation of NADPH oxidase, the mitochondrial electron transport chain, advanced glycation end-products and uncoupled endothelial nitric oxide synthase, resulting in the development of oxidative stress (Fakhruddin et al. 2017a) . Interestingly, Ang II-induced generation of ROS, in turn, further intensifies the interaction between Ang II and AT 1 R, resulting in a vicious cycle of renal injury.
Renal proximal tubular cells play a pivotal role in Na + reabsorption, primarily via the apical Na + -H + exchanger (NHE) and the Na + -HCO 3 − cotransporter, where the reabsorbed intracellular Na + is pumped to the extracellular fluid through the basolateral sodium pump, i.e. the Na + -K + -ATPase (NKA). Interestingly, oxidative stress accompanied by enhanced Ang II activity stimulates Na + -H + exchanger 3 (NHE3) activity through increased Jak2-dependent calmodulin phosphorylation and phospholipase C activity in the proximal tubule, which causes increased sodium retention and contributes to an increase in BP (Banday & Lokhandwala, 2011) . This observation was supported by evidence that oxidative stress causes an imbalance in RAAS in favour of prohypertensive components in the renal cortex and in in vitro renal proximal cells, which contribute to antinatriuretic effects resulting in increased fluid retention and higher blood pressure (Luo et al. 2015) . In addition, streptozotocin-induced diabetes and/or Ang II infusion increased mRNA and protein levels of the NKA α 1 -subunit in the renal cortex (Fekete et al. 2008) . Angiotensin II also directly activates the NKA α 1 -subunit through phosphorylation of serine residues on specific peptide segments, which underlies the role of the α 1 -subunit in the efflux of intracellular sodium (Yingst et al. 2004 ).
In our previous study, a chronic hyperglycaemic and hypertensive rat model was developed through chronic oral and I.P. glucose loading for a 2 week period. Hyperglycaemia produced an elevation in blood pressure within all the groups. The mechanisms underlying elevated BP in glucose-fed rats are not well understood. Some studies showed that glucose-fed rats developed hypertension because of increased sympathetic activity. However, the present model was exposed to sustained hyperglycaemic conditions for a 2 week period; therefore, we proposed that the sustained hyperglycaemia promoted an increased exposure of high glucose to glomerular and tubular cells via increased glomerular filtration of glucose, which provoked glucose-mediated aberrant signalling pathways in local renal cells. Increased glucose uptake from the high-glucose-enriched tubular filtrate by tubular cells can locally induce oxidative stress and RAAS activation, leading to impairment in fluid homeostasis, as demonstrated in many diabetic animal models (Brezniceanu et al. 2007; Vallon & Thomson, 2012; Shin et al. 2016) .
Based on these observations, we hypothesized that hyperglycaemia resulting from chronic oral and I.P. glucose loading can induce Ang II production and oxidative stress in proximal tubular cells to promote increased sodium reabsorption. A hyperglycaemiainduced increase in Ang II and/or oxidative stress is likely to upregulate protein levels of Na + -K + -ATPase in the basolateral membrane of PT epithelial cells, which pumps intracellular Na + to the interstitial fluid, resulting in increased Na + reabsorption, followed by increased blood volume and eventual hypertension.
Methods

Ethical approval
All experiments were performed in accordance with the ethical principles of Experimental Physiology and approved by the University of Louisiana at Monroe Institutional Animal Care and Use Committee (approved protocol no. 15JUN-KEJ-01) in accordance with all federal regulations as detailed in the 10nth guide for use of laboratory animals in scientific experiments. The experiments were performed on male Sprague-Dawley rats (250-300 g; Harlan, Indianapolis, IN, USA), which were housed in controlled humidity (60 ± 10%), temperature (23 ± 2°C) and light (12 h-12 h light-dark cycle), with free access to normal/glucose-enriched food and water throughout the study. At the end of the study, animals were anaesthetized with a single dose of thiobutabarbital (Inactin; 120 mg kg −1 I.P.) and killed by cervical dislocation while under general anaesthesia. The investigators understand the ethical principles under which Experimental Physiology operates, and our work complies with this animal ethics checklist. 
Materials
Animals
Male Sprague-Dawley rats (250-320 g), were housed in a controlled environment and had free access to normal/ glucose-enriched food and water throughout the study.
In the present study, we followed a previously described protocol to create a hyperglycaemic and hypertensive rat model, which was developed through oral and I.P. glucose loading for a period of 2 weeks. We provided animals with glucose-enriched food and drinking water along with I.P. injection of glucose at the following dosages in the first week: feed, 80 g (kg body weight) −1 ; drinking water, 2 g (kg body weight) −1 ml −1 ; and injection, 2.25 g (kg body weight) −1 ml −1 . In the second week, the dosages were increased to the following: feed, 80 g (kg body weight) −1 ; drinking water, 2.5 g (kg body weight) −1 ml −1 ; and injection, 2.75 g (kg body weight) −1 ml −1 , to challenge the capacity of β-cells to secrete insulin for glucose homeostasis, according to the protocol of Fakhruddin et al. (2017b) . We used the following four groups of animals: control; glucose treated; glucose treated with captopril (G+captopril); and glucose treated with tempol (G+tempol). Mechanism of production of hypertension by chronic hyperglycaemia
Experimental protocol
Before the study, animals were individually housed and randomly divided into the following four groups: control (n = 6); glucose treated (n = 6); glucose treated with captopril (n = 9); and glucose treated with tempol (n = 9). Fresh glucose-enriched food and water were prepared every morning according to the dose detailed in the previous subsection and supplied to all groups except the control group before the injection. The injection dose was also prepared every morning and preserved until the evening dose. To sustain plasma glucose concentrations over the second week, we had to increase slightly the glucose dosage in drinking water and injection in the second week. As we could not exceed a certain volume and concentration in the injection as well as in the drinking water to avoid animal discomfort at the outset of the study, we only increased the glucose dosage slightly with injection and water in the second week, which did not differ from the initial dosage in terms of volume and concentration because body weight was also slightly decreased. For all groups, glucose concentrations were monitored using a TRUE test glucose meter in the morning (08.00-09.00 h, before injection) and evening (19.00-20.00 h, 3 h after injection) by drawing a tiny blood drop (ß0.5 μl) from the tail of restrained animals, and the average glucose concentrations of two readings were recorded. In addition to glucose, G+captopril and G+tempol groups were given captopril (8 mg kg −1 day −1 ) and tempol (100 μmol kg −1 day −1 ), respectively, by I.P. injection as a single dose each day with the morning dose of glucose. Captopril is an ACE inhibitor to block Ang II production, whereas tempol is an antioxidant that neutralizes ROS, thereby inhibiting the development of oxidative stress. At the end of the study (on the 15th day), blood was collected to measure insulin concentrations.
Food was freshly prepared daily by mixing the required amount of glucose with standard rat chow (powder form) and reconstituting it into a ball with a small quantity of tap water. Based on previous studies in our laboratory, rats were determined to consume an average of 50 g of food daily; therefore, the glucose dosages were calculated based on the animal's weight to provide a daily allowance of at least 50 g. Glucose-enriched drinking water was prepared by simply dissolving the required amount of glucose in water.
Surgical procedure
At the end of the final study day (on the 15th day), surgeries were performed on animals. Before the start of surgery, all animals were examined to ensure that they were adequately anaesthetized by testing the pedal withdrawal reflex (footpad pinch on both hindfeet). If the footpad pinch caused a response, an additional amount of anaesthetic was injected and retested before starting the procedure. The surgical procedures were similar to those described previously (Alanazi et al. 2016; Fakhruddin et al. 2017b) . Briefly, rats were anaesthetized with a single dose of thiobutabarbital (Inactin; 120 mg.kg −1 I.P.). The carotid artery, jugular vein and bladder were cannulated for haemodynamic evaluation, saline infusion and urine sampling, respectively. In order to facilitate breathing, rats were intubated with a tracheal cannula (PE-240; Becton Dickinson, Sparks, MD, USA). After the cannulation procedures, rats were positioned on the right flank, and a small left flank incision was made to expose the left kidney. CMA 30 linear microdialysis probes were inserted into the renal cortex of the exposed kidney for renal interstitial sample collection, and the kidney was carefully replaced into the abdominal cavity, followed by closure of the incision by surgical packing. The inlet tube of the inserted probe was attached to a microinfusion pump for infusion of physiological saline (3 μl min −1 ). The outlet tube was connected to Eppendorf tubes for sample collections. The carotid catheter was already connected to a pressure transducer coupled with a polygraph system (Biopac Systems, Aero Camino Goleta, CA, USA) and a personal computer. As previously described, a 45 min stabilization period was observed, and after this stabilization period the blood pressure and heart rate were recorded continuously for a period of 4 h.
Sample collection
Collection of renal interstitial fluid and urine. After surgery, a 45 min recovery period was observed, followed by a 4 h interstitial fluid and urine collection from all groups. For interstitial fluid collection, physiological saline was infused at a rate of 3 μl min −1 through the inlet tube, and renal interstitial fluid was collected via the outlet tube of the probe. Urine was collected through the bladder catheter. At the end of the 4 h haemodynamic assessment and sample collection, blood was sampled from the carotid artery, and the right kidney and heart were extracted. Kidneys and hearts were snap-frozen immediately after extraction in liquid nitrogen-cold isopentane. All samples and organs were stored at −80°C until analysis. Plasma was obtained by immediate centrifugation and stored at −80°C.
Immunofluorescence laser-catapult microdissection of proximal tubules. Serial 10-μm-thick frozen sections were cut from the kidney cortex, in a Leica 1860 cryostat, and mounted on polyethylene terephthalate (PET) membrane slides (Carl Zeiss Microscopy GmbH, Königsallee, Göttingen, Germany). For dissection of proximal tubules, cortical segment staining was adapted from the sequential process of fluorescence staining previously described by others (Micanovic et al. 2015) .
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At least 100,000-200,000 μm 2 proximal tubule was catapulted into a tube containing 30 μl NP40 cell lysis buffer (Life Technologies, Frederick, MD, USA).
Sample analysis
Measurement of plasma glucose and insulin. Blood samples were obtained from the tail vein and analysed for glucose concentrations using a TRUE test glucose meter in all the groups (n = 6 per group). Plasma insulin concentrations were measured using commercially available rat insulin ELISA kits (Life Technologies, Frederick, MD, USA).
Determination of Ang II concentrations.
Dialysates from all groups were collected and freeze dried. Powdered samples were reconstituted (2 × concentrated) using the 1 × EIA assay buffer supplied with the ELISA kits. An ELISA was performed on the concentrated interstitial fluid samples to determine the concentration of Ang II present by comparison with a standard curve.
Analysis of plasma and urine for electrolytes. Plasma and urine were analysed for sodium and potassium electrolytes using an IL943 automatic flame photometer.
Determination of superoxide and peroxynitrite free radicals by electron paramagnetic resonance spectroscopy (EPR). Oxidative stress was analysed using a versatile non-destructive analytical technique, EPR. As previously described, superoxide (O 2 − ) and peroxynitrite (ONOO − ) were determined in the kidney cortex by using an EPR spectrometer (Prathipati et al. 2015) . The spin probes CMH (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine.HCl) and CPH (1-hydroxy-3-carboxy-2,2,5,5-tetramethylpyrrolidine.HCl) were used as spin trapping reagents to trap O 2 − and ONOO − , respectively, for measurement by the EPR spectrometer. Briefly, kidney tissues were cut into 2-mm-thick similar slices immediately before the experiment, and tissue slices were incubated for 1 h at 37°C in 0.5 ml of Krebs/Hepes buffer (pH 7.4) containing 25 μM deferoxamine (DF) and 5 μM diethyldithiocarbamate (DETC) along with 5 mM of CMH or CPH. After incubation, an EPR capillary tube was filled with the sample solution to be ready for EPR analysis. Blood pressure (mean arterial pressure, MAP) was measured via tail cuff-plethysmography (n = 6 per group). Values are shown as means + SD. * P < 0.05 glucose versus control and # P < 0.05 for glucose versus G+captopril or G+tempol group on days 0, 3, 6, 9 and 14 (two-way ANOVA followed by Bonferroni post hoc test). When the time factor was considered, the blood pressure change was not significant on days 3 and 6 for all groups except captopril. However, the blood pressure change was significant only on day 6 for control versus glucose, and glucose versus G+tempol group when tested individually using Student's unpaired t test. 
Statistical analyses
Data were expressed as means ± SD and analysed by two-way ANOVA followed by Bonferroni multiple comparison test when appropriate (GraphPad InStat 3, La Jolla, CA, USA). Some data were also analysed using one-way ANOVA followed by Tukey-Kramer tests or Student's unpaired t test when appropriate. In ELISA, the sample from each animal was plated in duplicate on a 96-well immunoplate, and the average absorption of the two readings for that animal was taken. All Western blot experiments were in triplicate. A value of P < 0.05 was considered significant.
Results
Food and water intake and body weight
Glucose-enriched food and water consumption and body weight were recorded as the average of the first and second week values. Food and water intake and body weight were significantly decreased in glucose-, captopriland tempol-treated animals when compared with control animals (data not shown). However, there was no significant change in food and water consumption when compared within the same group. Body weight was significantly decreased in the first and second week compared with the initial body weight within the group, and the second week body weight reduction was relatively greater than that in the first week; there were no significant differences between the groups.
Glucose treatment
Glucose concentrations began to increase significantly from day 3 (170 ± 71 mg dl −1 ) to day 6 (199 ± 110 mg dl −1 ), and continued to increase progressively and significantly from day 9 (223 ± 57 mg dl −1 ) to day 12 (321 ± 81 mg dl −1 ) in the glucose-treated group when compared with the control group. Moreover, measurements in a small subset of glucose-treated animals from day 13 showed a similar glucose concentration to day 14, indicating that a peak and sustained elevation in blood glucose concentration was achieved. However, glucose concentrations did not significantly increase until the second week in G+captopril (264 ± 88 and 282 ± 84 mg dl −1 on day 9 and 12, respectively) and G+tempol groups; the G+tempol group showed a significant increment in glucose concentration only on Values are shown as means + SD. * P < 0.05 control versus glucose and # P < 0.05 for glucose versus G+captopril or G+tempol group (one-way ANOVA followed by Tukey-Kramer post hoc tests). B, heart rate; there was no significant difference in HR between all groups.
day 12 (180 ± 43 mg dl −1 ), and both groups showed a similar glucose concentration on days 13 and 14 (Fig. 1) . Figure 2 shows that glucose treatment produced a significant increase in circulating insulin concentrations (25 ± 13 μIU ml −1 ) compared with the control group (16 ± 9 μIU ml −1 ). The observed hyperglycaemiamediated increase was attenuated by treatment with either captopril (10 ± 1 μIU ml −1 ) or tempol (11 ± 3 μIU ml −1 ).
Development of hyperinsulinaemia
Development of hypertension
In addition to sustained hyperglycaemia induced by the dietary intervention, BP started to increase, albeit not significantly, from the beginning of glucose feeding and injection, which led to a significant increase by day 9 (129 ± 18 mmHg) to day 12 (135 ± 26 mmHg) compared with control group day 9 (92 ± 11 mmHg) and day 12 (95 ± 12 mmHg; Fig. 3 ) and at the end of the study (day 15: glucose group, 129 ± 6 mmHg versus control group, 103 ± 10 mmHg; Fig. 4A ). The glucose-mediated increase in BP was returned to control levels by both captopril (day 9, 85 ± 19 mmHg and day 12, 84 ± 12 mmHg; Fig. 3 ) and tempol (day 9, 105 ± 12 mmHg and day 12, 113 ± 17 mmHg; Fig. 3 ) treatments. This attenuation in glucose-mediated hypertension was also observed at the end of the study (day 15: G+captopril, 95 ± 9 mmHg and G+tempol, 102 ± 12 mmHg; Fig. 4A ). However, there were no significant differences in heart rate between the different treatment groups (Fig. 4B ).
150
Ang ll (pg.ml Figure 5 shows a significant increase in renal interstitial Ang II concentrations in the glucose-treated group (99 ± 6 pg ml −1 ) compared with the control group (47 ± 2 pg ml −1 ). The observed increase in renal interstitial Ang II concentrations was returned to control values in the G+captopril group (51 ± 4 pg ml −1 ) and attenuated in the G+tempol group (63 ± 6 pg ml −1 ).
Determination of renal interstitial angiotensin II concentrations
Development of oxidative stress
Glucose-treated animals had an increased O 2 − [3.5 ± 1.1 × 10 7 arbitrary units (a.u.); Fig. 6B ] and OONO − (1.2 ± 2.8 × 10 7 a.u.; Fig. 6D ) in comparison to control rats (O 2 − , 1.8 ± 2.0 × 10 6 a.u., Fig. 6B ; and OONO − , 6.8 ± 2.0 × 10 6 a.u., Fig. 6D ) as determined by EPR in the renal cortical tissue. Development of oxidative stress was confirmed by evaluating the expression Nox2 protein levels in PT, which increased significantly in glucose-treated animals (5.8 ± 1.3 × 10 6 a.u. × 10 5 ± 1.3 × 10 6 a.u.), whereas captopril (4.1 ± 8.2 × 10 5 a.u.) and tempol (2.2 ± 4.3 × 10 5 a.u.) treatments reduced the protein to control levels (5.0 ± 10.0 × 10 5 a.u.; Fig. 7B ). Figure 8A shows that there was a significant decrease in urine flow mediated by glucose treatment (2 ± 1 ml min −1 ) compared with the control group (6 ± 1 ml min −1 ). The glucose-mediated decrease in urine flow was returned to control values by G+captopril (7 ± 2 ml min −1 ) and G+tempol (6 ± 2 ml min −1 ) treatments (Fig. 8A) . Glucose treatment produced a significant reduction in sodium excretion (0.2 ± 0.02 ml min −1 ; Fig. 8B ) and an increase in plasma sodium concentrations (142 ± 6 ml min −1 ; Fig. 8C ) compared with the control group (sodium excretion, 0.6 ± 0.2 ml min −1 , Fig. 8B ; plasma sodium, 133 ± 1 ml min −1 , Fig. 8C ). The observed decrease in sodium excretion and increase in plasma sodium was returned to control values in the G+captopril (sodium excretion, 0.7 ± 1 ml min −1 , Fig. 8B ; plasma sodium, 133 ± 6 ml min −1 , Fig. 8C ) and G+tempol (sodium excretion, 0.7 ± 0.2 ml min −1 , Fig. 8B ; plasma sodium, 135 ± 2 ml min −1 , Fig. 8C ) groups.
Measurement of urine flow, urinary sodium excretion and plasma sodium concentrations
Laser capture microdissection of the PT and analysis for Na + -K + -ATPase α 1 -subunit and phospho-Na + -K + -ATPase α 1 -subunit (Ser 18) Figure 9A shows the PET-stained image of the glomerulus (yellow oval) and PT (in red) before laser capture microdissection. Glucose-treated animals had an increased NKA α 1 -subunit expression in the PT (0.4 ± 0.009 a.u.; Fig. 9C ) in comparison to control animals (0.2 ± 0.005 a.u.; Fig. 9C ). The increase in NKA α 1 -subunit expression in the PT was attenuated by G+captopril (0.2 ± 0.03 a.u.; Fig. 9C ) and G+tempol (0.2 ± 0.02 a.u.; Fig. 9C ) treatments. Furthermore, glucose treatment (0.2 ± 0.007 a.u.; Fig. 9E ) produced a significant reduction in phospho-NKA α 1 -subunit (Ser 18) compared with the control group (0.4 ± 0.01 a.u.; Fig. 9E ). There was a significant increase in the NKA α 1 -subunit expression to phospho-NKA α 1 -subunit (Ser 18) ratio in the glucose-treated (1.1) compared with control animals (0.69). The observed glucose-mediated reduction in phospho-NKA α 1 -subunit (Ser 18) was returned to control levels by G+captopril (0.4 ± 0.01 a.u.; Fig. 9E ) and G+tempol (0.4 ± 0.01 a.u.; Fig. 9E ) treatments. In addition, the ratio of NKA α 1 -subunit expression to phospho-NKA α 1 -subunit (Ser 18) was returned to control levels in the G+captopril (0.63) and G+tempol groups (0.68).
Discussion
There was a progressive and sustained increase in glucose concentrations beginning on day 3 that was mediated by glucose treatments. Interestingly, this observation, along with our previous study (Fakhruddin et al. 2017b) , indicates that BP can be increased in glucose-fed animals regardless of their plasma glucose concentrations, as long as the BP increment is sustained by a consistent increase in blood glucose and insulin concentrations. The increase in BP can be attributed to enhanced production of Ang II, a potent vasoconstrictor, accompanied by increased generation of superoxide and peroxynitrite free radicals, with consequent development of oxidative stress in the kidney cortex. In addition, glucose-treated animals demonstrated high plasma insulin concentrations at the end of the 2 week study. Conversely, kidney cortical concentrations of Ang II, and oxidative stress as well as plasma insulin concentrations were significantly reduced in captopril-and tempol-treated animals, resulting in decreased blood pressure. This indicates that the RAAS, oxidative stress in the kidney cortex and/or hyperinsulinaemia are involved in the observed hypertension in this hypertensive and hyperglycaemic rat model.
It is evident in some other studies that animals fed glucose-enriched diets may develop hypertension accompanied by hyperinsulinaemia and variable plasma glucose concentrations (normal to moderate hyperglycaemia) depending on the nutrient concentration and duration of feeding, implying that hypertension may develop regardless of plasma glucose concentrations in glucose-fed animals (Kaufman et al. 1991; Reaven & A and B present a protein blot and the quantified density of protein blots when normalized to β-actin for all groups. A significant increase in Nox2 expression was observed in the glucose-treated group compared with the control group, whereas expression was significantly reduced in G+captopril and G+tempol groups when compared with the glucose-treated group. * P < 0.05 control versus glucose and # P < 0.05 for glucose versus G+captopril or G+tempol group (one-way ANOVA followed by Tukey-Kramer post hoc tests). Ho, 1991; Midaoui & de Champlain, 2002) . Some studies showed that hypertension in glucose-fed normal subjects is caused by increased sympathetic nervous system activity, and the sympathetic nervous system activity-mediated increase in blood pressure is predominantly caused by hyperinsulinaemia, although hyperglycaemia might also be involved (Rowe et al. 1981; Kaufman et al. 1991) . Given that our study showed sustained hyperglycaemia in response to repeated oral and I.P. glucose loading, hyperglycaemia induced in this way is likely to increase the exposure of high glucose concentraions to the glomerular and tubular cells through hyperfiltration, an effect similar to the one encountered during prediabetes (Vallon & Thomson, 2012) . Increased glomerular filtration results in increased glucose in the tubular filtrate, most of which is reabsorbed in the early proximal tubule by the high-capacity sodium-dependent glucose transporter 2 (SGLT2), and the remaining luminal glucose is taken up in further distal parts of the proximal tubule by the low-capacity SGLT1, leading to an increased intracellular concentration of glucose in proximal epithelial cells.
A high intracellular glucose concentration can evoke abnormal signal transduction pathways, leading to pathophysiological functions of the PT. One of the abnormalities attributable to hyperglycaemia in diabetic settings is the upregulation of both local and systemic RAAS components. Interestingly, the PT increases local expression and production of various pro-hypertensive RAAS components, including angiotensinogen, ACEs, AT 1 R and Ang II, which play a pivotal role in the pathomechanisms of diabetic nephropathy, as evident in growing body of studies (Zhang et al. 2002; Kobori et al. 2007; Luo et al. 2015) . In the present study, a significant increase in Ang II production in renal interstitial fluid was observed. Angiotensin II, a potent pressor hormone, plays a crucial role in not only vasoconstriction, but also in fluid retention in the PT. Renal Ang II mediates its hypertensive effects through interaction with both local and systemic AT 1 R that results in both intra-and extrarenal vasoconstriction, increased cardiac contractility and increased sodium reabsorption in the renal tubules, both directly and via increased aldosterone secretion from the adrenal gland (Crowley et al. 2006; Navar, 2010) . Angiotensin II can also induce the generation of superoxide by activating NADPH oxidase, a superoxide-generating machinery, promoting intrarenal oxidative stress. In addition to NADPH oxidase, other diverse pathways, including the mitochondrial electron transport chain, advanced glycation end-products and uncoupled endothelial nitric oxide synthase, can induce the development of oxidative stress in the diabetic milieu (Fakhruddin et al. 2017a) .
Furthermore, hyperglycaemia can also induce intrarenal oxidative stress via other mechanisms, where increased intracellular glucose concentrations in proximal epithelial cells can pose a risk of diverting glucose to different metabolic pathways instead of the glycolytic pathway, which is not a common pathway because proximal tubular cells do not use glucose for energy production. For example, high glucose in diabetic subjects is likely to undergo the polyol/sorbitol pathway, auto-oxidation, de novo synthesis of diacylglycerol and non-enzymatic glycation (production of advanced glycation end-products), thus increasing the susceptibility of proximal tubular cells to the enhanced generation of ROS, followed by the development of oxidative stress (Forbes et al. 2008; Dunlop, 2000) . It is intriguing to note that Ang II and ROS can induce each other, thus exhibiting a vicious cycle of pressor effects in the kidney cortex. This is evident in our study, where we found attenuated Ang II concentrations in tempol-treated animals, whereas captopril-treated animals showed decreased superoxide and peroxynitrite generation.
The increased expression of Nox2 in the present study is in contrast to other studies, which demonstrated increased Nox4 expression in the PT, followed by the development of oxidative stress in diabetes (Sedeek et al. 2010) . This discrepancy can be attributed to the animal strains, disease model and in vitro versus in vivo protein expression. However, multiple lines of evidence show diabetes-induced upregulation of Nox2 in the renal cortex, indicating the involvement of Nox2 in the development of renal oxidative stress during diabetes, consequently, in the development of hypertension and diabetic nephropathy (Ohshiro et al. 2006; Sedeek et al. 2013) .
In the present study, we demonstrated that Ang II and/or ROS in the renal cortex increased blood pressure by enhancing sodium retention in the proximal tubule, which is supported by the findings that excretion of Na + in urine and urine flow were significantly reduced in glucose-treated animals, and that treatment with captopril or tempol attenuated this response. Increased reabsorption of Na + into the circulatory system was confirmed, in that a significantly higher concentration of Na + in the plasma was measured. These findings are consistent with those of other studies that exhibited increased intrarenal oxidative stress and RAAS . Measurement of urine flow, sodium excretion, and plasma sodium levels A, urine flow was significantly decreased in the glucose-treated animals, but increased in G+captopril and G+tempol groups. B, in line with decreased urine flow, urinary sodium excretion was significantly decreased in the glucose-treated group, but increased in the captopril-and tempol-treated groups. C shows increased conservation of plasma sodium in the glucose-treated group, but reduced plasma sodium concentration in captopril-and tempol-treated animals. These observations together imply that increased sodium is retained by the kidney. Values are shown as means + SD. * P < 0.05 control versus glucose and # P < 0.05 for glucose versus G+captopril or G+tempol group (one-way ANOVA followed by Tukey-Kramer post hoc tests). A, 10-μm-thick tissue sections were cut in a cryostat and mounted on Polyethylene terephthalate (PET) slides, followed by serial staining as described in the protocol. The sections were observed under immunofluorescence-laser capture microscopy to catapult proximal tubule. The image A shows a glomerulus (outlined in yellow) and proximal tubule (outlined in red). B and D exhibit protein blots, while C and E present the quantified density of protein blots from proximal tubule lysates when normalized to β-actin for all groups. A significant increase in Na + -K + -ATPase α 1 -subunit expression was activation (e.g. pro-pressor components) to be underlying mechanisms for increasing reabsorption of Na + and water, contributing to increased blood volume and eventual blood pressure (Mervaala et al. 1999; Luo et al. 2015) . Moreover, elevated levels of OONO − production in the present study supported the hypothesis that increased O 2 − generation reacts with NO to form potent and versatile oxidant peroxynitrite (OONO − ), thereby scavenging NO, an important vasodilator, to promote renovascular vasoconstriction and hypertension. This observation is supported by evidence that blunted intrarenal NO generation increases tubular sodium reabsorption, leading to increased arterial pressure (Navar, 2005) . In addition, the hyperinsulinaemia observed in our study can potentially be involved in Na + reabsorption through induction of Na + -K + -ATPase in the proximal tubule, as evident in other studies (Baum, 1987; Féraille et al. 1999) . However, the exact role of interaction between insulin and glucose to promote proximal tubule Na + retention needs to be determined in this animal model.
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Increased production of Ang II and the development of oxidative stress in the renal cortex caused increased sodium and water retention, which suggests that the PT is playing a key role in causing volume expansion and elevated blood pressure. Nonetheless, the mechanism by which increased sodium reabsorption occurs in this model is not clear. Hence, the role of the Na + -K + -ATPase, an ion pump largely responsible for transporting intracellular Na + out of the cells into interstitial fluid followed by its reabsorption into circulation through peritubular capillaries, was determined. Proximal tubular cells were microdissected and isolated from the heterogeneous cellular environment, and PT cell lysates were obtained. An increased expression of the NKA α 1 -subunit, which catalyses Na + -K + -ATPase activity, was determined by Western blot analysis; this represents an increase in functional Na + transport activity (Salyer et al. 2013 ). In addition, we measured the expression of phospho-NKA α 1 -subunit at the Ser 18 residue to confirm basal activity of this protein pump corresponding to the increased NKA α 1 -subunit expression. We found that phospho-NKA α 1 -subunit levels were decreased in observed in the glucose-treated group compared with the control group, whereas expression was reduced significantly in G+captopril and G+tempol groups when compared with the glucose-treated group (B and C). Conversely, phosphorylated Na + -K + -ATPase α 1 -subunit (Ser 18) was attenuated in the glucose group, whereas captopril-or tempol-treated animals showed significantly increased phosphorylation. The ratio of Na + -K + -ATPase α 1 -subunit expression to phosphorylated Na + -K + -ATPase α 1 -subunit was 0.69 in the control group, 1.1 in the glucose group, 0.63 in the G+captopril group and 0.68 in the G+tempol group. * P < 0.05 control versus glucose and # P < 0.05 for glucose versus G+captopril or G+tempol group (one-way ANOVA followed by Tukey-Kramer post hoc tests).
glucose-treated animals, whereas captopril and tempol elevated its levels. This is crucial to understanding the activity of basal NKA α 1 -subunit, because its phosphorylation at Ser 18 increases its internalization by the endosome, thus reducing its activity (Chibalin et al. 1997; Pedemonte et al. 2005) . The present study showed that both captopril and tempol treatments returned this ratio to control levels. Therefore, the ratio of expression of NKA α 1 -subunit to phospho-NKA α 1 -subunit is a good index of NKA α 1 -subunit activity, with an increase in the ratio being indicative of enhanced activity (Feschenko & Sweadner, 1997; Hatou et al. 2010) . We found that decreased phosphorylation of Ser 18 of the NKA α 1 -subunit in the glucose group reduced its internalization, thereby upholding its increased activity exerted by already overexpressed NKA α 1 -subunit. Phosphorylation at Ser 18 by different hormones, such as dopamine, can inhibit the pumping activity of NKA (Efendiev & Pedemonte, 2006) , which supports our observations that Ser 18 phosphorylation of the NKA α 1 -subunit is an underlying mechanism for regulation of pump activity of NKA in the rat proximal tubule. Although various ion channels, such as SGLT2, SGLT1, NHE3 and Na + -Cl − cotransporter, which are located in the apical membranes of PT epithelial cells, can participate in Na + reabsorption from the lumen into the intracellular compartment, NKA is involved in transporting the intracellular Na + into the interstitial fluid. Given this characteristic, the expression and/or stimulation of NKA plays a potential role in fluid retention. However, additional studies are needed to confirm its relative magnitude in Na + reabsorption by analysing and comparing other ion channels of the PT in this rat model.
Consistent with previous reports, we found an elevation in Ang II and oxidative stress, which could promote NKA-mediated sodium reabsorption and consequent hypertension (Wang et al. 2009 ). Moreover, apparent scavenging of NO by O 2 − can also affect the activity of the NKA. Studies suggest that blunted intrarenal NO bioavailability can induce pump activity of the NKA in the basolateral membrane of PT epithelial cells. This confers an additive effect of Na + retention to the already existing active sodium-retaining pathways stimulated by the RAAS and oxidative stress (Hakam & Hussain, 2006; Banday & Lokhandwala, 2008) . Additionally, insulin can also induce NKA-mediated sodium reabsorption in the PT (Féraille et al. 1999) , which causes amplification of the already increased extracellular fluid volume and blood pressure.
In summary, the present study demonstrates sustained hyperglycaemia and hypertension as a result of feeding glucose-enriched diets accompanied by I.P. glucose injection in Sprague-Dawley rats. Hypertension caused by this dietary intervention results from the high-glucoseinduced increase in the generation of Ang II and development oxidative stress in the renal cortex. Angiotensin II and/or oxidative stress promote enhanced Na + retention through the PT by potentially increasing the expression and activity of the Na + -K + -ATPase in glucose-treated animals. An upregulation of Na + -K + -ATPase can increase pumping of Na + from interior sites of epithelial cells in the basolateral membrane of the proximal tubule to the interstitial fluid followed by increased Na + reabsorption into the peritubular capillaries. As a result, it significantly increases the Na + concentration in plasma, leading to increased blood volume and eventual hypertension. Treatment with captopril and tempol significantly reduced Na + -K + -ATPase expression and sodium reabsorption, followed by a significant attenuation of blood pressure in this hypertensive hyperglycaemic rat model.
